<table id="_Refinv-350df7df-51c9-4eb8-9bc6-4910085b" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 7. Mean Pharmacokinetic Parameters<sup>a</sup> of Immediate-Release Lamotrigine in Healthy Volunteers and Adult Subjets With Epilepsy </caption>
<col width="25%"></col>
<col width="23%"></col>
<col width="27%"></col>
<col width="25%"></col>
<tfoot>
<tr>
<td align="left" colspan="8" stylecode="Botrule" valign="top">
<sup>a</sup> The majority of parameter means determined in each study had coefficients of variation between 20% and 40% for half-life and CL/F and between 30% and 70% for T<sub>max</sub>. The overall mean values were calculated from individual study means that were weighted based on the number of volunteers/subjects in each study. The numbers in parentheses below each parameter mean represent the range of individual volunteer/subjects values across studies. </td>
</tr>
<tr>
<td align="left" colspan="8" stylecode="Botrule" valign="top">
<sup>b</sup> Carbamazepine, phenytoin, phenobarbital, and primidone have been shown to increase the apparent clearance of lamotrigine. Estrogen-containing oral contraceptives and other drugs such as rifampin and protease inhibitors lopinavir/ritonavir and atazanavir/ritonavir that induce lamotrigine glucuronidation have also been shown to increase the apparent clearance of lamotrigine [<content stylecode="italics">see Drug Interactions (<linkhtml href="#inv-fcad0e17-6c73-405f-8562-e8171a0e3ffc">7</linkhtml>)].</content>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Adult Study Population</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Number of Subjects</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">t<sub>Â½</sub>: Elimination Half-life<sup>h</sup> (hr)</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">CL/F: Apparent Plasma Clearance (mL/min/kg)</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">Healthy volunteers taking no other medications:</content>
</paragraph>
<paragraph>Single-dose lamotrigine </paragraph>
<paragraph>Multiple-dose lamotrigine</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>179</paragraph>
<paragraph> 36</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>32.8 </paragraph>
<paragraph>(14.0-103.0) </paragraph>
<paragraph>25.4 </paragraph>
<paragraph>(11.6-61.6)</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>0.44 </paragraph>
<paragraph>(0.12-1.10) </paragraph>
<paragraph>0.58 </paragraph>
<paragraph>(0.24-1.15)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">Healthy volunteers taking valproate</content>:</paragraph>
<paragraph> Single-dose lamotrigine </paragraph>
<paragraph>Multiple-dose lamotrigine</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>6</paragraph>
<paragraph>18</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>48.3</paragraph>
<paragraph> (31.5-88.6)</paragraph>
<paragraph> 70.3 </paragraph>
<paragraph>(41.9-113.5)</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>0.30 </paragraph>
<paragraph>(0.14-0.42) </paragraph>
<paragraph>0.18 </paragraph>
<paragraph>(0.12-0.33)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">Subjects with epilepsy taking valproate only:</content>
</paragraph>
<paragraph>Single-dose lamotrigine</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>4</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>58.8 </paragraph>
<paragraph>(30.5-88.8)</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 0.28 </paragraph>
<paragraph>(0.16-0.40)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">Subjects with epilepsy taking carbamazepine, phenytoin, phenobarbital, or primidoneb plus valproate:</content>
</paragraph>
<paragraph> Single-dose lamotrigine</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>25</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>27.2 (11.2-51.6)</paragraph>
</td>
<td stylecode="Rrule Lrule Botrule ">
<paragraph> 0.53 (0.27-1.04)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule ">
<paragraph>
<content stylecode="bold">Subjects with epilepsy taking carbamazepine, phenytoin, phenobarbital, or primidone:</content>
<sup>b</sup>
</paragraph>
<paragraph>Single-dose lamotrigine </paragraph>
<paragraph>Multiple-dose lamotrigine</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule ">
<paragraph>24</paragraph>
<paragraph>17</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule ">
<paragraph>14.4 </paragraph>
<paragraph>(6.4-30.4) </paragraph>
<paragraph> 12.6</paragraph>
<paragraph> (7.5-23.1)</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule ">
<paragraph>1.10 </paragraph>
<paragraph>(0.51-2.22) </paragraph>
<paragraph> 1.21 </paragraph>
<paragraph>(0.66-1.82)</paragraph>
</td>
</tr>
</tbody>
</table>